CCL2 and breast carcinoma: We then measured CCL2 mRNA expression (Supplementary Fig. 5a) and its release from various viable and apoptotic breast cancer cell lines along with HMEC, which corroborated a positive correlation of miR-375 levels and CCL2 expression (Fig. 2d, Supplementary Fig. 5b).